The Swiss stock market continued to rise on Monday morning, like most other European markets. Two weeks before the inauguration of future American President Donald Trump, investors’ nervousness was increasing in the face of the unpredictability of the future tenant of the White House.
For Mirabaud Banque expert John Plassard, “questions concerning political issues in Europe and the United States two weeks before the inauguration of Donald Trump could reverse the positive trend”.
“The current problem could be that European markets are nervous before the inauguration of Donald Trump,” added analyst Frank Sohlleder of Activtrades. Without clear indication from Wall Street, “the situation remains difficult for investors,” he added.
In China, growth in the services sector rebounded in December to its highest level in seven months, according to the Purchasing Managers’ Activity Index (PMI) for services, calculated by S&P Global and the business media. Chinese Caixin.
In Switzerland, retail turnover took advantage of the rising cost phenomenon to increase by 0.8% in November year-on-year, excluding the effects of working days and public holidays.
Investors will also be watching the PMI index in the euro zone and inflation in Germany this Monday.
Shortly before 10:45 a.m., the flagship SMI index rose 0.08% to 11,633.70 points, paring its gains after opening up 0.25%. The SLI also remained in the green and accelerated by 0.27% to 1926.84 points and the SPI gained 0.17% to 15,544.26 points.
In a business news situation still in a state of complete calm after the end-of-year holidays, the majority of star stocks remained in the green.
The largest increases were still recorded by VAT Group (+4.6%) which increased its gains, Logitech (+2.2%) and Richemont (+2.0%). Stifel analysts have raised the price target for the Geneva luxury giant.
At the other end of the table were now Swiss Re (-1.1%), Lindt (-0.9%) and Nestlé (-0.8%).
On the broader market, DocMorris (-5.5%) reinforced its losses, after several lowering of its price target.
Cicor (stable) has finalized the acquisition of the German service provider for the development and manufacturing of electronic modules and systems Profectus.
Santhera (+3.0%) was wanted. The laboratory has extended the geographic distribution of its Duchenne muscular dystrophy treatment Agamree (vamorolone) to new, unspecified countries.
Vontobel (+0.3%) put an end to the takeover of IHAG Privatbank customers. The latter had already announced the cessation of its management activities after the transaction. (AWP)
